All In Biotech

NDA 020488 · Hospira

Magnesium Sulfate In Dextrose 5% In Plastic Container

Magnesium Sulfate · Injection

Last checked: Nov 19, 2026Latest source record: Apr 16, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1995

Jul 11, 1995

Approved uses

1

Original approval plus efficacy supplements

Registered trials

0

0 Phase 3, 0 recruiting

FAERS reports

102

89 serious, 18 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Aug 24, 2026.

Magnesium Sulfate in 5% Dextrose Injection is indicated for: • Prevention of eclampsia in patients with preeclampsia • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia Magnesium Sulfate in 5% Dextrose Injection is indicated for ( 1 ): • Prevention of eclampsia in patients with preeclampsia ( 1 ) • Treatment of seizures and prevention of recurrent seizures in patients with eclampsia ( 1 )

Mechanism: Magnesium prevents seizures in patients with preeclampsia and controls seizures in patients with eclampsia by blocking neuromuscular transmission and decreasing the amount of acetylcholine liberated at the end plate by the motor nerve impulse. Magnesium has a depressant effect on the central nervous system [see Drug Interactions (7) ] . Magnesium acts peripherally to produce vasodilation.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Jul 11, 1995 Original approval · Type 3 - New Dosage Form Review
2 products under this application
  • MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER · MAGNESIUM SULFATE 1GM/100ML · INJECTABLE, INJECTION · Prescription · TE AP
  • MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER · MAGNESIUM SULFATE 2GM/100ML · INJECTABLE, INJECTION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Magnesium Sulfate In Dextrose 5% In Plastic Container" as an intervention, any sponsor and status, largest first.

All 0 trials

No registered drug trials name this ingredient.

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug ineffective22
  • exposure during pregnancy11
  • off label use11
  • hypermagnesaemia8
  • maternal exposure during pregnancy8
  • acute kidney injury7
  • pulmonary oedema7
  • hyperglycaemia6
  • bile duct obstruction5
  • blood bilirubin increased5
  • diarrhoea5
  • pyrexia5

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
20132
20141
20153
20167
20174
20189
20198
20201
202116
202224
202317
20244
20251
20265

Recalls

1 FDA enforcement reports for this application.

  • Mar 6, 2015 · Class I · Terminated

    Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in sodium chloride...

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 0 on PubMed

No PubMed clinical studies matched.

Sponsor: Pfizer

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.